Web Analytics

Investor Profile

The Column Group

The Column Group United States - San Francisco, CA
INVESTOR

1 Disclosed Funding Rounds $160,000,000
5 Participating Investments




The Column Group (TCG) is a science-driven venture capital firm that makes significant financial and operational commitments to build early stage drug discovery companies based on their uniqu

Invested In

Company Date Round Raised
  Carmot Therapeutics, Inc. July, 26 ,2022 Series D $160,000,000
  Atavistik Bio December, 26 ,2023 Unknown $40,000,000
  Remix Therapeutics January, 04 ,2024 Unknown $60,000,000
  Tr1X January, 19 ,2024 Series A $75,000,000
  Kenai Therapeutics March, 01 ,2024 Series A $28,000,000